Anto Biosciences
A frontier biology AI lab developing foundation models to make the gut microbiome computable for drug development.
About Anto Biosciences
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving the hidden root cause of most drug failures.
Founded by Arvid (Broad Institute of MIT and Harvard; Nature-published researcher who pioneered quality-aware, goal-directed sparsification) and David (Harvard Medical School Gastroenterology, J&J), second-time founders who published the breakthrough at leading machine learning AI conferences and Nature.
Products
Multimodal foundation models for microbial communities, making the gut microbiome computable for the first time.
Enables the prediction of drug toxicity and efficacy across diverse populations and optimizes molecules for broader efficacy, addressing microbiome-driven causes of drug respons...
Security and compliance
No security details published yet
Anto Biosciences hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Anto Biosciences